AREDS2 Clinical Data
These data are not intended for analysis and should be used only for sample selection purposes. For analyses, the actual Central GA, any GA and NV AMD fields from the fundus grading datasets (AREDS2_RCA and AREDS2_RCF) are available in the AREDS2 dbGaP. |
| dbGaP Submitter Subject Id |
AR2_0674 |
| Consent Status |
GRU - General Research Use |
| Control |
No |
| Age (Yrs) |
85 |
| Gender |
Male |
| Race |
White |
| Ethnicity |
Hispanic or Latino |
| RE Baseline AMD Severity Scale |
4 - AREDS AMD Severity Scale Step 4 |
| RE Final AMD Severity Scale |
3 - AREDS AMD Severity Scale Step 3 |
| RE Final Graded Visit |
Year 5 |
| LE Baseline AMD Severity Scale |
11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| LE Final AMD Severity Scale |
11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| LE Final Graded Visit |
Year 5 |
| Data Definition References |
Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10 (2016)
doi: 10.1001/jamaophthalmol.2016.2383; PMID: 27442263; PMCID: PMC8371745
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 (2005)
doi: 10.1001/archopht.123.11.1484; PMID: 16286610; PMCID: PMC1472813 |
| Other Study References |
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression AREDS2 Report 28 (2022)
doi: 10.1001/jamaophthalmol.2022.1640; PMID: 35653117; PMCID: PMC9164119
Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group (2016)
doi: 10.1016/j.ophtha.2016.12.004; PMID: 28089680
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) (2012)
doi: 10.1016/j.ophtha.2012.05.027; PMID: 22840421; PMCID: PMC3485447 |